Bococizumab

Product Name: Bococizumab
CAS No.: 1407495-02-6
Chemical Name: Bococizumab
Synonyms: Bococizumab;RN316|||PF-04950615;Bococizumab 6.17mg/ml;Bococizumab (anti-PCSK9);Research Grade Bococizumab;Research Grade Bococizumab(DHJ24004)
CBNumber: CB68080899
Formula Weight: 0
MOL File: Mol file

More

Less

Bococizumab Property

form: Liquid
color: Colorless to light yellow

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

Bococizumab Chemical Properties,Usage,Production

Uses

Bococizumab (PF-04950615) is an anti-human PCSK9 inhibitory antibody that reduces LDL cholesterol levels. Bococizumab can be used in the research of hypercholesterolemia[1][2].

in vivo

Bococizumab (0-100 mg/kg, i.v.) decreases maternal and fetal cholesterol and does not affect rat embryo-fetal development^[2].

Animal Model:	Pregnant Sprague-Dawley (SD) rats^[1]
Dosage:	0, 10, 30, and 100 mg/kg
Administration:	Intravenous injection (i.v.)
Result:	Decreased in fetal cholesterol levels. Showed well tolerance and no effects on ovarian or uterine parameters.

References

[1] Koutaro Yokote, et al. Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive - Results From a Randomized, Placebo-Controlled, Dose-Ranging Study. Circ J. 2017 Sep 25;81(10):1496-1505. DOI:10.1253/circj.CJ-16-1310
[2] Sarah N Campion, et al. Decreased maternal and fetal cholesterol following maternal bococizumab (anti-PCSK9 monoclonal antibody) administration does not affect rat embryo-fetal development. Regul Toxicol Pharmacol. 2015 Nov;73(2):562-70. DOI:10.1016/j.yrtph.2015.08.007

Bococizumab Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Bococizumab Suppliers

China 20 India 1 United States 2 Global 23

BOC Sciences

Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Country: United States
ProdList: 12952
Advantage: 65

Shanghai YuanYe Biotechnology Co., Ltd.

Tel: 021-61312847; 18021002903
Fax: QQ:3008007432
Email: 3008007409@qq.com
Country: China
ProdList: 71826
Advantage: 60

ShangHai Biochempartner Co.,Ltd

Tel: 177-54423994 17754423994
Fax: QQ:2853530913
Email: 2853530910@QQ.com
Country: China
ProdList: 8000
Advantage: 62

TargetMol Chemicals Inc.

Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Country: United States
ProdList: 32435
Advantage: 58

DC Chemicals

Tel: 021-58447131 13564518121
Email: doncunbiosci@gmail.com
Country: China
ProdList: 544
Advantage: 58

Guangzhou Hongyuan Chemical Co.,Ltd

Tel: 15817493340
Email: 981810490@qq.com
Country: China
ProdList: 1566
Advantage: 58

Wuhan Chemstan Biotechnology Co., Ltd.

Tel: 027-65317797 15926423062
Fax: QQ：422450190
Email: 422450190@qq.com
Country: China
ProdList: 10308
Advantage: 58

TargetMol Chemicals Inc.

Tel: 4008200310
Email: marketing@tsbiochem.com
Country: China
ProdList: 24961
Advantage: 58

Biolab Reagents

Tel: 027-65279366 18108604356
Email: products@biolabreagent.com
Country: China
ProdList: 9868
Advantage: 58

Wuhan Jingkangen Biomedical Technology Co., Ltd

Tel: 13720134139 086-15871494362 13720134139
Email: orders@jknbiochem.com
Country: China
ProdList: 6762
Advantage: 58

1407495-02-6, BococizumabRelated Search:

Diridavumab Edrecolomab Foravirumab Matuzumab Codrituzumab Vofatamab Toripalimab Utomilumab Lenvervimab TocilizuMab

Bococizumab

Research Grade Bococizumab(DHJ24004)

RN316|||PF-04950615

Research Grade Bococizumab

Bococizumab (anti-PCSK9)

Bococizumab 6.17mg/ml

1407495-02-6